Dupilumab in Japanese Patients With Atopic Dermatitis

Clinical trial NCT04678882 · COMPLETED

Trial details

NCT number: NCT04678882
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Atopic Dermatitis

Start date: 2021-01-15
Primary completion: 2021-12-14
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.